Home > Boards > US OTC > Cannabis > North American Cannabis Holdings Inc. (USMJ)

I know where PR is getting his information,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
weavor Member Profile
Followed By 2
Posts 70
Boards Moderated 0
Alias Born 08/24/17
160x600 placeholder
PJET CEO Indicates Cryptocurrency Strategy In The Works InvestorsHub NewsWire - 12/10/2021 9:42:16 AM
PURA Farmersville Hemp Targets $13B CBD Market And $41B Sustainability Market InvestorsHub NewsWire - 12/6/2021 1:01:13 PM
PJET Student Housing Alternative To Launch As Student Housing Shortage Exacerbated By Covid Economic Impact InvestorsHub NewsWire - 11/8/2021 9:48:12 AM
PURA and PAOG Partner With UCASU in Cannabis Real Estate Deal InvestorsHub NewsWire - 11/4/2021 9:02:36 AM
PJET Expands Short-Term Rental Market With SHBO App For College Students InvestorsHub NewsWire - 11/4/2021 8:54:40 AM
PJET Announces Brick and Mortar Student Housing Project To Complement App InvestorsHub NewsWire - 11/1/2021 2:10:18 PM
ALYI, PAOG, And WSGF Are Surging In October; Near Term Catalysts Make Them A Micro-Cap Power Play InvestorsHub NewsWire - 10/28/2021 1:37:33 PM
PURA Stock Closes Near Four Month Highs As Partnership With PAOG Accelerates Move Into Hemp And CBD Sectors InvestorsHub NewsWire - 10/21/2021 12:51:11 PM
PAOG Reveals CBD Products Under Development For $100 Billion Pet Market InvestorsHub NewsWire - 10/20/2021 10:01:17 AM
PAOG - PAO Group, Inc. Stock Gains 220% Since September; Announces Commercial Launch Of First CBD Nutraceuticals Product Through Partner USMJ InvestorsHub NewsWire - 10/19/2021 11:25:23 AM
PAOG To Launch Second CBD Nutraceutical Product Later This Week Further Ramping Up 2021 Revenue Potential InvestorsHub NewsWire - 10/18/2021 2:53:43 PM
Shares Jump as Firm Launches CBD Sleep Aid AllPennyStocks.com - 10/18/2021 11:52:00 AM
PAOG Introduces RelaxRX CBD Targeting $100 Billion Sleep Aid Market InvestorsHub NewsWire - 10/18/2021 10:06:45 AM
PAOG Cites New British Medical Journal Case Report On CBD Lung Cancer And COPD Treatment As Validation Of PAOG Ongoing RespRx Drug Research InvestorsHub NewsWire - 10/15/2021 9:36:18 AM
Investment in CBD Nutraceuticals Paying Off AllPennyStocks.com - 10/14/2021 3:36:00 PM
PAOG Announces Imminent Launch Of First CBD Nutraceutical Product Line - Q4 Sales Projected With Rapid Revenue Growth Anticipated To Follow InvestorsHub NewsWire - 10/12/2021 11:53:47 AM
PAOG Ships First CBD Nutraceutical Product To Distributor Entering $16 Billion Market InvestorsHub NewsWire - 10/7/2021 11:46:58 AM
PURA Farmersville Hemp Brand Timed To Catch Wave Of Celebrity Support InvestorsHub NewsWire - 10/6/2021 2:22:06 PM
PURA, USMJ, PAOG and PJET Momentum Builds On Technical Milestones InvestorsHub NewsWire - 10/5/2021 1:21:49 PM
PJET - A New Opportunity Taking Flight Soon InvestorsHub NewsWire - 10/5/2021 10:43:11 AM
PAOG To Build On CBD Business Through Acquisition InvestorsHub NewsWire - 10/5/2021 10:42:28 AM
PAOG plans expansion through to complement existing CBD business Seeking Alpha - 10/4/2021 11:41:03 AM
weavor   Friday, 05/04/18 09:49:29 AM
Re: None
Post # of 84171 
I know where PR is getting his information, but he is leaving out the other stuff that comes with it.

From within the statement itself:

Series D Preferred Stock
On September 18, 2013, the Company filed a certificate of designation of Series
D Preferred Stock and the Company issued 100,000 shares of Series D preferred
stock to the former shareholders of Algae (See Note 1). Pursuant to the certificate
of designation:
• 100,000 shares were designated as Series D Preferred Stock.
• Holders of the Series D Preferred Stock will be entitled to receive $1.00 per
share of Series D Preferred Stock, prior to any distribution to holders of
common stock, in the event of any liquidation, dissolution or winding up of
the Company.
• Holders of Series D Preferred Stock will be entitled to receive dividends in
the amount of 51% of net income, payable quarterly.
• Holders of Series D Preferred Stock will own 51% of the voting power of
the shareholders of the Company.
The Company may not redeem shares of Series D Preferred Stock without the
written consent of the holders thereof.
On June 05, 2017, ownership of these shares were transferred to ACI
Conglomerated, LLC.

We can find that here

Basically the 51% goes to ACI which we all knew. Thats what parent companies do. At the most each quarter ACI will get $100,000. Now if we continue to trade at 3/4/5 then they will get the most profit and there will be only a few thousand left for USMJ to profit from themselves. When the shares reached 7/8/9 people got excited and sold driving it back down. Now USMJ did not make a large profit due to this. Mostly because like us ACI is greedy and want quick money.

My suggestion even though we dont make anything now we need to buy at the higher price to drive it up so it can survive until laws change. Then we will be good.

This is just my opinion.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences